BiondVax Pharmaceuticals Ltd. BVXV
1.36 +1.36
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -11.06M | -10.87M | 2.07M | -22.11M | -21.75M | |
| -5.80M | -8.21M | -1.26M | -30.82M | -24.76M | |
| -4.00 | -8.00 | -1.13 | -37.26 | -38.39 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 14.21M | 17.52M | 2.66M | 20.45M | 21.42M | |
| 27.07M | 32.04M | 16.06M | 32.67M | 29.87M | |
| 28.83M | 31.05M | 20.18M | 51.03M | 38.68M | |
| 21.54M | 28.98M | 18.96M | 37.05M | 26.63M | |
| -1.76M | 982.00K | -4.12M | -18.36M | -8.81M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -7.26M | -7.43M | -20.47M | -21.75M | -16.14M | |
| -836.00K | -139.00K | -1.68M | -2.03M | -6.62M | |
| 6.78M | 21.43M | 3.87M | 24.05M | 23.80M | |
| -836.00K | -139.00K | -1.69M | -2.10M | -6.66M | |
| -3.30M | 14.44M | -17.79M | -964.17K | 1.27M |